Search

everythinglearnresearchcommunity

for

Search:↓

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Early over-expression of FoxN1 harms immune and skin development.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Entospletinib effectively prevents eye and skin GVHD in mice.

Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.

A holistic approach is crucial for treating skin disorders and restoring barrier function.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.